Latest News
October 28, 2011
"Questioning the Risk Profile of Selegiline Hydrochloride" Poster exhibit presented by Dr. Emory at Institute on Psychiatric Services Conference, San Francisco.
May 15-18, 2011
“Questioning the Risk Profile of Selegiline Hydrochloride” Poster exhibit presented by Dr. Emory at American Psychiatric Association Conference, Honolulu.
Patient Testimonials

The Craft of Axis III
A New Axis III Craft for Medical Doctors:
Detect & Improve Neurophysiologic Variations
“Variability is the law of life, and as no two faces are the same, so no two bodies are alike, and no two individuals react alike and behave alike under the abnormal conditions which we know as disease.”
Sir William Osler


An invisible misery can signal the onset of a
brain-based mental disorder. Lacking a way to
identify the individual neurobiology of these
disorders, medical doctors and psychiatrists
have sorted symptoms and behaviors as the
primary means of selecting medication. Other
doctors may presume a psychological impair-
ment and not consider an underlying neuro-
pathology. The result can lead to psychotherapy
without an adequate clinical assessment.

I practiced traditional psychiatry for nearly a
decade and was disappointed in my treatment
outcomes. Beginning an EEG & QEEG research
project in 1986, I gradually learned how to recognize and analyze EEG patterns and QEEG measures and how they change with medications that pass the blood-brain barrier.

Applying the medical rule to “sort physiology first”, I developed a clinical procedure on Axis III to improve a patient’s distressful symptoms that I had labeled on Axis I. In this procedure, a prospective patient’s EEG data is compared with a large, clinical outcome database of heterogeneous EEG’s and their diverse medication responses. The prospective patient’s EEG data is then mathematically classified and correlated with neuro-active medication(s) likely to improve their particular brain function.

Applying this approach in treating thousands of patients over the last two decades, my understanding about mental disorders has changed.

I now realize that healthy persons are merely genetically fortunate. They can enjoy predictable physical and mental wellbeing without much effort. Yet, those with chronic mental disorders and/or substance abuse do not have that physiological capacity. They are physically ill with conditions for which we have no names, but an increasing understanding of how to personalize a health restoring medicinal regimen.

My experience with applying individual EEG data in clinical practice has convinced me that persons with a brain-based mental disorder are trying to find relief from their abnormal neurobiology. They find ways to help themselves through persistent substance abuse, bingeing, purging, restricting food, obsessions, compulsions, self-mutilation, inward or outward aggression and/or violence, etc. Such behaviors change physiology and give transitory relief. Although the behaviors appear maladaptive, they are attempts at adaptation.

When a behavior such as these partially relieves the pathophysiology associated with a mental disorder, a behavior is reinforced and becomes habitual. The goal of my medical treatment is to provide a more effective and safe medical regimen for these patients than they previously devised.

My neuro-psychiatric approach collects, sorts and integrates physical findings with physiological facts about each person’s bodily systems and interactions. The comprehensive scope of a patient centered medical inquiry increases knowledge of individual brain activity and brain-body interface.

Now, medical doctors can be trained in new Axis III skills that I have learned over the years. They can also learn to follow this EEG & QEEG pattern recognition technique. Knowledge-based treatment improves medical outcomes and reduces the stigma of undesirable habits.

- Hamlin Emory, M.D.